A bipartisan effort in the U.S. Senate seeks to improve the safety of infant formula. Introduced by Sen. John Hoeven, R-ND, and Sen. Gary Peters, D-MI, ...

There were unforgiveable shortcomings in management, which included critical information not reaching senior officials as ...

Abbott Laboratories on Wednesday forecast first-quarter profit below Wall Street as weakness in nutrition and diagnostics units overshadowed strength in medical devices, sending its shares down more ...

Here’s some basic arithmetic for you: The proposed school voucher bill approved tonight in the Texas Senate is cruel in at least five fundamental ways.

A product made in Columbus reached a major milestone at the end of 2024. Ensure, a nutritional drink made by Abbott ...

The alarm certainly sounded long and loud in 2022 when Abbott recalled Similac, Alimentum, and EleCare powdered infant formulas after an FDA investigation ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

The lawsuit accuses Abbott of creating products called “transition formulas,” “follow-on formulas,” “weaning formulas” and “toddler milks” to boost earnings as infant formula sales ...

Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Abbott Nutrition's roots go back to the 1920s when the Moores & Ross Milk Co. in Columbus began producing milk-based infant formula. That business became Ross Laboratories in 1956, and was bought ...